Mechanisms and models in heart failure: A combinatorial approach

Circulation. 1999 Aug 31;100(9):999-1008. doi: 10.1161/01.cir.100.9.999.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cardiotonic Agents / therapeutic use
  • Disease Progression
  • Diuretics / therapeutic use
  • Heart Failure / complications*
  • Heart Failure / drug therapy
  • Heart Failure / etiology
  • Heart Failure / physiopathology*
  • Humans
  • Hypertrophy, Left Ventricular / complications*
  • Hypertrophy, Left Ventricular / etiology
  • Hypertrophy, Left Ventricular / physiopathology*
  • Stroke Volume
  • Vasodilator Agents / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiotonic Agents
  • Diuretics
  • Vasodilator Agents